Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

1330 - GATA6 exhibits tumor suppressive effects in hepatocellular carcinoma

Date

11 Sep 2017

Session

Poster display session

Topics

Cancer Biology;  Hepatobiliary Cancers

Presenters

Han Wei Tan

Citation

Annals of Oncology (2017) 28 (suppl_5): v1-v21. 10.1093/annonc/mdx361

Authors

H.W. Tan1, C. Leung2, K. Chan2, I. Ng3, R. Lo3

Author affiliations

  • 1 Pathology, The University of Hong Kong, 990 - Hong Kong/HK
  • 2 Pathology, The University of Hong Kong, Hong Kong/HK
  • 3 Pathology, State Key Laboratory For Liver Research, The University of Hong Kong, Hong Kong/HK
More

Resources

Abstract 1330

Background

GATA6 is a transcription factor that regulates endoderm differentiation and lineage specification. Dysregulation of GATA6 expression had been reported in cancers of endoderm-derived organs such as the lungs, stomach and pancreas. The aim of this study is to determine the clinical significance of GATA6 in hepatocellular carcinoma (HCC) and characterize its potential functional roles.

Methods

GATA6 mRNA expression was assessed in 74 clinical HCC samples by quantitative polymerase chain reaction (qPCR). Correlation between GATA6 expression and clinicopathological parameters was analyzed. Stable GATA6 knockdown clones were established by a lentiviral-based approach in HCC cell line Huh7, which showed relatively high endogenous GATA6 expression. Functional effects upon GATA6 manipulation were investigated by cell proliferation, migration, invasion and tumorsphere formation assays in vitro.

Results

GATA6 expression was significantly downregulated in HCC tumor tissues when compared with the corresponding non-tumoral liver tissues (p = 0.007). A lower GATA6 expression was correlated with poorer cellular differentiation (p = 0.004). Silencing of GATA6 stimulated HCC cell proliferation, and promoted cell invasive and migratory abilities in vitro. This increase in metastatic capacity was mediated through the activation of epithelial-mesenchymal transition (EMT), as demonstrated by the loss of E-cadherin and gain of vimentin protein expression levels. Suppression of GATA6 augmented the self-renewal ability of HCC cells as demonstrated by the enhanced number and size of tumorspheres formed in both primary and secondary generations. In addition, the expression of various stemness markers such as Nanog, Oct4 and Sox2 were upregulated upon GATA6 silencing.

Conclusions

Our findings suggest that GATA6 is downregulated in HCC which may help to convert HCC cells to a more poorly differentiated state and enhance proliferation, self-renewal ability and metastatic potential.

Clinical trial identification

Legal entity responsible for the study

Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.